Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
Rhode Island Hospital
mi
from
Providence, RI
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
Medical University of South Carolina
mi
from
Charleston, SC
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
The Methodist Hospital Research Institute
mi
from
Houston, TX
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
The Methodist Hospital Research Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
University of Virginia
mi
from
Charlottesville, VA
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
West Virginia University
mi
from
Morgantown, WV
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
Dalhousie Univerisity
mi
from
Halifax,
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
Dalhousie Univerisity
mi
from
Halifax,
Click here to add this to my saved trials
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated:  2/19/2018
Washington University
mi
from
Saint Louis, MO
Hydrogel Endovascular Aneurysm Treatment Trial
New Generation Hydrogel Endovascular Aneurysm Treatment Trial
Status: Enrolling
Updated: 2/19/2018
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Tuscaloosa, AL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Anaheim, CA
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Glendale, CA
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Oceanside, CA
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Orange, CA
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
San Bernardino, CA
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
San Bernardino, CA
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
San Diego, CA
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Denver, CO
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
New Haven, CT
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Stamford, CT
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Stamford, CT
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Boca Raton, FL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Gainesville, FL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Lake City, FL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Lake City, FL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Miami, FL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Orlando, FL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Port Charlotte, FL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Chicago, IL
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Baltimore, MD
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Kansas City, MO
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Raleigh, NC
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Cleveland, OH
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Charleston, SC
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Memphis, TN
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Fort Worth, TX
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Minneapolis, MN
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Asheville, NC
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Durham, NC
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
mi
from
Prague,
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
mi
from
Prague,
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Washington,
Aim to Reduce Movements in Tardive Dyskinesia
A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Long Beach, CA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
National City, CA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
San Bernardino, CA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
San Bernardino, CA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
San Diego, CA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Upland, CA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Hialeah, FL
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Tampa, FL
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated:  2/19/2018
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Adult Subjects With Tourette Syndrome
Status: Enrolling
Updated: 2/19/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials